Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

This study examines whether adding Compound Kushen Injection (a traditional Chinese herbal medicine) to standard chemotherapy improves survival and quality of life for people with advanced colorectal cancer receiving first-line treatment. **You may be eligible if...** - You are 18 or older - You have advanced colorectal cancer confirmed by pathology and are receiving first-line (initial) therapy - You have a good performance status (ECOG 0–2) - You have at least one measurable tumor lesion - Your expected survival is at least 3 months **You may NOT be eligible if...** - You are receiving treatment other than first-line therapy - You have no measurable tumor - Your expected survival is less than 3 months Talk to your doctor to see if this trial is right for you.